HomeFileCoronary disease

Coronary disease

View Category

Coronary disease

Should Total Occlusion Influence on Revascularization Strategy?

Success or failure of total occlusion (TO) revascularization does not affect mortality at 10 years, and this...
solaci -
Learn More
Acute coronary syndromes

MATRIX: Impact of Crossover from Radial Access to Femoral Access

The new MATRIX trial, recently published in JACC Interv., shows that an access-site crossover from radial to...
solaci -
Learn More
Chronic Ischemic cardiopathy

Medical Therapy Optimization Achieved Prior Clinical Trial

12 weeks prior the ORBITA randomization, medical therapy optimization of all antianginal medication was achieved.   Most importantly, optimization...
solaci -
Learn More
Antiplatelet

Net Clinical Benefit of Long-Term Ticagrelor

Ticagrelor reduces ischemic risk in patients with a history of acute myocardial infarction, but it increases the...
solaci -
Learn More
Chronic Ischemic cardiopathy

Revascularization Is Needed Before TAVR

Disease prevalence in patients with severe aortic stenosis is highly variable: from 80% in inoperable patients to...
solaci -
Learn More
Chronic Ischemic cardiopathy

Last Bastion of Bare Metal Stents Finally Falls

Multiple studies have shown the safety and efficacy of drug eluting stents (DES) in patients with high...
solaci -
Learn More
Coronary disease

08/03 | Webinar SOLACI – CACI@Boston Scientific – Día Internacional de la Mujer: Hablemos de Género en Cardiología Intervencionista

solaci -
Learn More
Bifurcations

03/03 | SOLACI Webinar – Left Main PCI and Bifurcations: LATAM Bif Registry

We invite you to participate in the first free SOLACI virtual event of 2021. It is carried...
solaci -
Learn More